Institute of Systems Biomedicine, Department of Pathology, School of Basic Medical Sciences, Peking-Tsinghua Center for Life Sciences, Peking University Health Science Center, Beijing 100191, China; State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University Health Science Center, Beijing 100191, China.
Institute of Systems Biomedicine, Department of Pathology, School of Basic Medical Sciences, Peking-Tsinghua Center for Life Sciences, Peking University Health Science Center, Beijing 100191, China.
Cell Rep. 2022 Jul 12;40(2):111071. doi: 10.1016/j.celrep.2022.111071.
Non-alcoholic fatty liver disease (NAFLD) is the most common liver disease, with a prevalence of 25% worldwide. However, the underlying molecular mechanism involved in the development and progression of the NAFLD spectrum remains unclear. Single-stranded DNA-binding protein replication protein A1 (RPA1) participates in DNA replication, recombination, and damage repair. Here, we show that Rpa1 mice develop fatty liver disease during aging and in response to a high-fat diet. Liver-specific deletion of Rpa1 results in downregulation of genes related to fatty acid oxidation and impaired fatty acid oxidation, which leads to hepatic steatosis and hepatocellular carcinoma. Mechanistically, RPA1 binds gene regulatory regions, chromatin-remodeling factors, and HNF4A and remodels chromatin architecture, through which RPA1 promotes HNF4A transcriptional activity and fatty acid β oxidation. Collectively, our data demonstrate that RPA1 is an important regulator of NAFLD through controlling chromatin accessibility.
非酒精性脂肪性肝病 (NAFLD) 是最常见的肝脏疾病,全球患病率为 25%。然而,NAFLD 谱发展和进展中涉及的潜在分子机制仍不清楚。单链 DNA 结合蛋白复制蛋白 A1 (RPA1) 参与 DNA 复制、重组和损伤修复。在这里,我们表明 Rpa1 小鼠在衰老过程中和高脂饮食反应中会发展为脂肪性肝病。肝特异性敲除 Rpa1 导致与脂肪酸氧化相关的基因下调和脂肪酸氧化受损,导致肝脂肪变性和肝细胞癌。在机制上,RPA1 结合基因调控区域、染色质重塑因子和 HNF4A,并重塑染色质结构,通过这种方式,RPA1 促进 HNF4A 的转录活性和脂肪酸 β 氧化。总的来说,我们的数据表明,RPA1 通过控制染色质可及性成为 NAFLD 的一个重要调节因子。